1.23
Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of “Reduce” by Brokerages - Defense World
Is Pliant Therapeutics Inc a good long term investmentHead and Shoulders Patterns & Superior Portfolio Investment - earlytimes.in
Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre - Investing.com Nigeria
Pliant Therapeutics Announces Departure of Chief Medical Officer - TradingView
Pliant Therapeutics Inc (PLRX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Pliant Therapeutics shares rise after early cancer drug data impresses - MSN
Rishiroop Limited Recovery Likely Heres What Data ShowsVolume Analysis Techniques & Rapid Capital Portfolio - earlytimes.in
Pliant Therapeutics (PLRX) Stock Analysis Report | Financials & Insights - Benzinga
Pliant Therapeutics reports interim PLN-101095 Phase I trial data - Yahoo
Pliant’s PLN-101095 shows promising results in cancer trial By Investing.com - Investing.com Nigeria
Can Pliant Therapeutics Inc. stock sustain revenue growthJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser
What hedge fund moves indicate for Pliant Therapeutics Inc. (9PT) stockJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser
Can Pliant Therapeutics Inc. (9PT) stock double in coming yearsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - Newser
Why Pliant Therapeutics Inc. (9PT) stock could be top winnerBear Alert & Risk Controlled Daily Plans - Newser
Why Is Pliant Therapeutics Stock Trading Lower TodayPliant Therapeutics (NASDAQ:PLRX) - Benzinga
Pliant Therapeutics, Inc. (PLRX) -15.3% in Intraday Trading: Interim Data Announcement Fails to Support Price - Stocks Telegraph
Pliant Therapeutics stock jumps on promising cancer drug trial results By Investing.com - Investing.com South Africa
Pliant Therapeutics stock jumps on promising cancer drug trial results - Investing.com
Pliant Therapeutics, Inc. Announces Interim Data from Pln-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - marketscreener.com
Pliant’s PLN-101095 shows promising results in cancer trial - Investing.com
Pliant Therapeutics reveals promising early results for PLN-101095 - Traders Union
Pliant Therapeutics announces interim data from PLN-101095 - marketscreener.com
Pliant Therapeutics Announces Interim Data from PLN-101095 - GlobeNewswire
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - Sahm
Is Pliant Therapeutics Inc. (9PT) stock considered safe havenTrade Volume Report & Community Consensus Stock Picks - Newser
Are Smart Investors Making the Right Decision? Pliant Therapeutics Inc (PLRX) - setenews.com
Will Pliant Therapeutics Inc. (9PT) stock profit from fiscal stimulusMarket Risk Summary & Verified Swing Trading Watchlist - Newser
Will Pliant Therapeutics Inc. stock attract more institutional investors - Newser
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - Investing News Network
Pliant Therapeutics (Nasdaq: PLRX) to host Dec. 4 fireside chat at Piper Sandler - Stock Titan
Pliant Therapeutics Inc Stock Analysis and ForecastRSI Overbought/Oversold & Insights From Wall Street Professionals - earlytimes.in
What drives Pliant Therapeutics Inc stock priceCapital Gains Strategies & Access Advanced Stock Screening Tools - earlytimes.in
Wall Street analysts’ outlook for Pliant Therapeutics Inc (PLRX) - setenews.com
Total debt per share of Pliant Therapeutics, Inc. – SWB:9PT - TradingView
Pliant Therapeutics, Inc. (PLRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Why Pliant Therapeutics Inc. (9PT) stock benefits from AI revolutionWeekly Loss Report & Accurate Intraday Trading Signals - newser.com
Why Pliant Therapeutics Inc. stock is in analyst buy zone2025 Price Targets & Low Drawdown Investment Strategies - newser.com
How rising interest rates impact Pliant Therapeutics Inc. stockJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com
Pliant Therapeutics Inc (PLRX) expanding its growth trajectory ahead - Setenews
Why global investors buy Pliant Therapeutics Inc. (9PT) stock2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Pliant Therapeutics Inc.July 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):